Evidence map›Paper›PMID 38548964›Full record

ArticleScientific reports2024

Green synthesis of chitosan nanoparticles using tea extract and its antimicrobial activity against economically important phytopathogens of rice.

M Sathiyabama, R V Boomija, S Muthukumar, M Gandhi, S Salma, T Kokila Prinsha, B Rengasamy

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Eco-friendly nanoparticles fromNanoscale advances · 2026
    Article
  5. Article
  6. Eco-friendly synthesis of FeFrontiers in microbiology · 2026
    Article
  7. Enhanced Antioxidant and Anti-bacterial Potential ofCurrent medicinal chemistry · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Efficacy ofToxins · 2025
    Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

M SathiyabamaDepartment of Botany, School of Life Sciences, Bharathidasan University, Tiruchirappalli, Tamil Nadu, 620024, India. sathiyabama@bdu.ac.in.
R V BoomijaDepartment of Botany, School of Life Sciences, Bharathidasan University, Tiruchirappalli, Tamil Nadu, 620024, India.
S MuthukumarDepartment of Botany, School of Life Sciences, Bharathidasan University, Tiruchirappalli, Tamil Nadu, 620024, India.
M GandhiDepartment of Botany, School of Life Sciences, Bharathidasan University, Tiruchirappalli, Tamil Nadu, 620024, India.
S SalmaDepartment of Botany, School of Life Sciences, Bharathidasan University, Tiruchirappalli, Tamil Nadu, 620024, India.
T Kokila PrinshaDepartment of Botany, School of Life Sciences, Bharathidasan University, Tiruchirappalli, Tamil Nadu, 620024, India.
B RengasamyDepartment of Botany, School of Life Sciences, Bharathidasan University, Tiruchirappalli, Tamil Nadu, 620024, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the present work is to biosynthesize Chitosan nanoparticles (CTNp) using tea (Camellia sinensis) extract, with potent antimicrobial properties towards phytopathogens of rice. Preliminary chemical analysis of the extract showed that they contain carbohydrate as major compound and uronic acid indicating the nature of acidic polysaccharide. The structure of the isolated polysaccharide was analyzed through FTIR and

Indexed as

ChitosanNanoparticlesOryzaPlant ExtractsTeaChitosanPlant ExtractsTeaAntimicrobialChitosan nanoparticlesPyricularia griseaRiceTea polysaccharidesXanthomonas oryzae

Identifiers

PMID38548964
PMCPMC10978976

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.